Clinical Trials Logo

Mobility Limitation clinical trials

View clinical trials related to Mobility Limitation.

Filter by:

NCT ID: NCT05549999 Completed - Clinical trials for Duchenne Muscular Dystrophy

Cultural Adaptation, Validity, and Reliability of the Turkish Version of North Star Ambulatory Assessment

Start date: November 1, 2022
Phase:
Study type: Observational

The aim of this study is to translate the "North Star Ambulatory Assessment (NSAA)" scale into Turkish and make its cultural adaptation and to demonstrate the reliability and validity of the Turkish version in patients with ambulatory DMD. For the translation into Turkish, validity and reliability of the NSAA, necessary permission was obtained from the developer of the questionnaire, Prof. Dr. Francesco Muntoni, via e-mail. In the study, first of all, the translation and cultural adaptation process will be completed, and then reliability-validity studies will be carried out.

NCT ID: NCT05516030 Recruiting - Physical Disability Clinical Trials

HIFT for People With Mobility-Related Disabilities

Research GO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Investigators will examine the feasibility and health outcomes following a high-intensity functional training intervention for people with mobility-related disabilities. In addition to participant recruitment, attritions rates, and satisfaction, investigators will assess changes to both physical health outcomes (e.g., strength, body composition) and psychosocial outcomes (e.g., quality of life). The findings will provide evidence for the efficacy of HIFT to improve various health outcomes for a population that experiences health disparities in access to, and engagement in, community-based exercise.

NCT ID: NCT05501249 Completed - Cognitive Change Clinical Trials

Aquatic Exercise for Cognition and Mobility in Older Adults

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of an aquatic exercise program on cognition and physical function of older adults.

NCT ID: NCT05497648 Completed - Aging Clinical Trials

Evaluating Impact and Implementation of Choose to Move (Phase 3)

CTM
Start date: January 16, 2018
Phase: N/A
Study type: Interventional

The objectives of this study are to 1) evaluate whether Choose to Move (CTM) improves health outcomes in older adults who participate and 2) assess whether CTM is delivered as planned and what factors support or inhibit delivery at scale. CTM is a 6 month, choice-based program for low active older adults being scaled-up across British Columbia, Canada. The goals of CTM are to enhance physical activity, mobility and social connectedness in older adults living in British Columbia, Canada.

NCT ID: NCT05484063 Not yet recruiting - Mobility Limitation Clinical Trials

Help Optimise and Mobilise Elders (H.O.M.E)

HOME
Start date: July 25, 2022
Phase: N/A
Study type: Interventional

During hospitalisations, older inpatients commonly face issues such as immobility, loss of independence, and functional decline. This leads them down the cascade of dependency with consequent increased risk of adverse outcomes, institutionalisation as well as higher post-acute care costs. The investigators hypothesize that by implementing a mobility intervention in the inpatient setting, patients would be able to maintain their function upon discharge and avoid the cascade of dependency. As such, the investigators aim to do this by implementing and evaluating a mobility intervention, while optimising reversible factors affecting mobility among inpatients admitted to a geriatric unit in Singapore. The investigators will also examine the cost impact of a mobility focused model of care and also adopt the effectiveness-implementation hybrid Type 2 design where both effectiveness and implementation spheres are tested simultaneously.

NCT ID: NCT05473676 Active, not recruiting - Cerebral Palsy Clinical Trials

Robotic Walking for Children Who Cannot Walk

RoWaCaWa
Start date: July 4, 2022
Phase: N/A
Study type: Interventional

A common problem among children with nervous system disorders is difficulty walking on their own. This has impacts beyond mobility including short and long-term health conditions associated with physical inactivity and different developmental experiences as a result of the mobility impairments. A robotic trainer can both provide rehabilitation and be an assistive device to help compensate for difficulties. Figuring out how to prescribe it is critical to improve daily life for children with significant disabilities. Preliminary use of robotic trainers have shown many benefits, such as better head control and improved independence in transfers, which greatly increases ability to live independently. Additionally, vital functions that are frequently impaired in those with less physical activity, such as sleep and bowel habits, seem to improve. Finally, these children enjoy using them. This project aims to determine who is most likely to benefit from training with a robotic trainer and investigate key details about the dose of training that is needed. Families that are already using or hope to use robotic training need this data to help improve their access to the intervention. Clinicians need this systematic approach to building evidence to ensure a future multi-centre randomized control trial is well designed. This study is needed to help improve the lives of those who live with significant disabilities. The objective is to evaluate the feasibility and impacts of delivering robotic gait training at home. Integral in this study is capturing the user perspectives. This will both provide preliminary evidence-based advice to potential users, their families, and clinicians as well as provide key metrics to design a definitive multi-centre randomized control trial. The investigators will provide robotic gait trainers, specifically Trexo robotic gait trainers, to participants and their families to use in their home communities for 12 weeks to evaluate the feasibility and impacts of intensive robotic gait training in people who cannot walk independently. Assessments will be completed throughout the duration of study, including before, during, and after the training intervention, with the goal of evaluating a wide range of feasibility considerations and impacts from robotic training.

NCT ID: NCT05461677 Recruiting - Clinical trials for Gait Disorders, Neurologic

Walking With the SAIRE Smart Walker

SAIRE
Start date: November 2022
Phase: N/A
Study type: Interventional

The current study aims to investigate the effect of walking with the SAIRE smart walker on spatiotemporal parameters and gait kinematics in a population who suffer from difficulties during gait, and compare this to walking with a standard walker or no walking aid.

NCT ID: NCT05450666 Completed - Mobility Limitation Clinical Trials

Effectiveness of Mobility Exercises in Resistance-Trained Males With Shoulder Immobility in Different Age Groups

Start date: July 3, 2022
Phase: N/A
Study type: Interventional

The shoulder is a dynamic and mobile joint between the arm and the trunk. The movement of the joint in three dimensions performs complex movements in almost every activity of daily life. These movements performed during activities of daily living can cause musculoskeletal problems and shoulder pathologies. For this reason, the shoulder joint should be carefully evaluated, especially in athletes.

NCT ID: NCT05447299 Enrolling by invitation - Cerebral Palsy Clinical Trials

Neuromusculoskeletal Modeling of Muscle Spasticity

Start date: January 15, 2019
Phase:
Study type: Observational

Cerebral palsy (CP) is a movement and posture disorder caused by an injury to the developing brain, with a prevalence in Sweden of about 2/1000 live births. Children with CP have walking difficulties, and decreased muscle mass and muscle function as compared to typically developing (TD) children. The extent of disability in CP depends on the severity and timing of the primary cerebral lesion and can be classified with the gross motor function classification system (GMFCS E&R) that ranges from walking without limitations (I) to being transported in a wheelchair (V). Muscle function commonly deteriorates with age and contracture development is often clinically evident as early as at 4 years of age. In addition to being thinner and weaker, skeletal muscle in children with CP develop poor quality, i.e., increasingly higher amounts of fat and connective tissue at the expense of functional, contractile proteins. How long-term standard treatments for children with spastic CP including, training and orthotics use, with botulinum toxin (BoNT-A) treatment as an adjunct, affects muscle on functional, structural, and microscopic level in CP has not yet been published. Therefore, we will investigate the muscle function as well as functional mobility, structure, and spasticity. We will conduct functional mobility tests. Muscle strength will be measured with a rig-fixed dynamometer, and muscle structure will be measured with magnetic resonance imaging. The spasticity will be instrumentally assessed by the NeuroflexorTM, a machine measuring resistance in a muscle when a pedal is passively moving the participants foot at two different speeds. We will follow participants, for 1 year, with 4 measurements during this period. In order to better treat these children, we need to better understand the complex, interrelated interactions of musculoskeletal properties and function in children with CP. Our hypothesis is that muscle structure and function is affected by standard clinical treatments sessions including routine botulinum toxin treatment. Analyzing the effect of standard care may help planning of more effective clinical treatments in the future.

NCT ID: NCT05446987 Completed - Back Pain Clinical Trials

Position Change and Back Massage Versus Early Ambulation on Post Transfemoral Coronary Angiography Complications

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The study aimed to assess the effect of position change and back massage versus early ambulation on post transfemoral coronary angiography complications.